Fundraising Fox

Pharmaceutics International

Hunt Valley, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

SE
Syed E. AbidiFounder
JF
John FowlerExecutive
JH
Julien HechtExecutive
JD
Jillian DettingerExecutive
SE
Syed E Abidi, Ph.D.Named on SEC filing

Board

DS
David SolomonBoard director
MK
Mark KavulichBoard director
JGJames Gale
James GaleBoard directorFounding Partner & Managing Director at Signet Healthcare Partners
MBMichael Bogda
Michael BogdainBoard directorOperating Partner / Advisor at Signet Healthcare Partners
SI
Sana I. AbidiBoard director
SR
Shahid RazaBoard director

Investors · 1

Signet Healthcare Partnersreported · 2 sourcesNew York · $10M – $50M

Reported raises · per SEC filings

Form D private placements

$206.5M disclosed across 17 rounds · 2016–2024

▶$11.2MraisedOct 2024 · 3 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • David SolomonDirector
  • Mark KavulichDirector
  • Syed E Abidi, Ph.D.Director
  • John FowlerExecutive Officer, Director
  • Michael BogdaDirector
  • James GaleDirector
Offering amount
$11.2M
Amount sold
$11.2M
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedMar 2024 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James GaleDirector
  • Syed E. Abidi, Ph.D.Director
  • Mark KavulichDirector
  • John FowlerExecutive Officer, Director
  • Michael BogdaDirector
  • David SolomonDirector
  • Joseph KielyExecutive Officer
Offering amount
$4.2M
Amount sold
$4.2M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$6MraisedJun 2023 · 2 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John FowlerExecutive Officer, Director
  • Mark KavulichDirector
  • Syed E. Abidi, Ph.D.Director
  • Michael BogdaDirector
  • David SolomonDirector
  • James GaleDirector
  • Joseph KielyExecutive Officer
Offering amount
$12M
Amount sold
$6M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedDec 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph KielyExecutive Officer
  • Mark KavulichDirector
  • Michael BogdaDirector
  • John FowlerExecutive Officer, Director
  • Syed E. Abidi, Ph.D.Director
  • James GaleDirector
  • David SolomonDirector
Offering amount
$3M
Amount sold
$3M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9MraisedOct 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Syed E. Abidi, Ph.D.Director
  • James E. GaleDirector
  • John GuthrieExecutive Officer
  • Sana I. AbidiDirector
  • David SolomonDirector
  • John FowlerExecutive Officer, Director
  • Michael BogdaDirector
Offering amount
$9M
Amount sold
$9M
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedAug 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Syed E. Abidi, Ph.D.Director
  • David SolomonDirector
  • Shahab N. AbidiDirector
  • John GuthrieExecutive Officer
  • John I. FowlerExecutive Officer, Director
  • James E. GaleDirector
  • Michael BogdaDirector
Offering amount
$5M
Amount sold
$5M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJul 2022 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • James GaleDirector
  • Shahab N. AbidiDirector
  • Michael I. BogdaDirector
  • Syed E. AbidiDirector
  • John FowlerExecutive Officer, Director
  • John GuthrieExecutive Officer
  • David SolomonDirector
Offering amount
$5M
Amount sold
$5M
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMay 2022 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John FowlerExecutive Officer, Director
  • James GaleDirector
  • Michael BogdaDirector
  • John GuthrieExecutive Officer
  • Sana AbidiDirector
  • Syed E. AbidiDirector
  • David SolomonDirector
Offering amount
$5M
Amount sold
$5M
First sale
Apr 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Pharmaceutics International Raises $4.2M amid Sale Talk | citybizcitybiz.co · Mar 2024Hunt Valley Maryland based Pharmaceutics International is raising $5,000,319.00 in New Equity Investment. - intelligence360intelligence360.news · Jul 2022Hunt Valley’s Pharmaceutics International raises $93 millionbaltimoresun.com · Sep 2016

Frequently asked questions

Who founded Pharmaceutics International?
Pharmaceutics International was founded by Syed E. Abidi.
Who are Pharmaceutics International's investors?
Pharmaceutics International's investors include Signet Healthcare Partners.
How much funding has Pharmaceutics International raised?
Pharmaceutics International has disclosed $206.5M raised across 17 rounds.
Where is Pharmaceutics International headquartered?
Pharmaceutics International is headquartered in Hunt Valley, US.